Theme

Semiconductors

The chip supply chain — designers, equipment and components.

51 covered names · ranked by fair value vs price

Cirrus Logic Inc (CRUS)

BUY. 12-month probability-weighted target $133 (+24% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

CRUSEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +32.0%

Equity Research

Cerebras Systems Inc. Class A Common Stock (CBRS)

BUY. 12-month probability-weighted target $206 (+25% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBRSEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +21.3%

Equity Research

First Solar Inc. (FSLR)

BUY. 12-month probability-weighted target $230 (+29% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

FSLREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +18.0%

Equity Research

Amkor Technology Inc (AMKR)

BUY. 12-month probability-weighted target $61 (+24% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

AMKREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +14.0%

Equity Research

NXP Semiconductors NV (NXPI)

HOLD. 12-month probability-weighted target $263 (+15% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

NXPIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +12.7%

Equity Research

KLA Corporation (KLAC)

BUY. 12-month probability-weighted target $245 (+25% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

KLACEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.2%

Equity Research

Qnity Electronics, Inc (Q)

BUY. 12-month probability-weighted target $151 (+19% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

QEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +6.3%

Equity Research

Allegro Microsystems Inc (ALGM)

BUY. 12-month probability-weighted target $46 (+29% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

ALGMEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +6.3%

Equity Research

ON Semiconductor Corporation (ON)

HOLD. 12-month probability-weighted target $87 (+12% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

ONEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.1%

Equity Research

Qualcomm Incorporated (QCOM)

HOLD. 12-month probability-weighted target $174 (-1% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

QCOMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.7%

Equity Research

Universal Display (OLED)

HOLD. 12-month probability-weighted target $79 (+5% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

OLEDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.7%

Equity Research

Microchip Technology Inc (MCHP)

HOLD. 12-month probability-weighted target $83 (+9% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

MCHPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.7%

Equity Research

Enphase Energy Inc (ENPH)

HOLD. 12-month probability-weighted target $34 (+4% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

ENPHEquity ResearchMonte Carlo

11 October 2026Rating: HOLD · Fair value vs price +3.4%

Equity Research

Coherent Inc (COHR)

BUY. 12-month probability-weighted target $371 (+19% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

COHREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +3.2%

Equity Research

Applied Materials Inc (AMAT)

HOLD. 12-month probability-weighted target $621 (+23% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

AMATEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.2%

Equity Research

Qorvo Inc (QRVO)

HOLD. 12-month probability-weighted target $114 (-1% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

QRVOEquity ResearchMonte Carlo

11 October 2026Rating: HOLD · Fair value vs price -1.3%

Equity Research

MKS Instruments Inc (MKSI)

HOLD. 12-month probability-weighted target $285 (+8% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

MKSIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.0%

Equity Research

Advanced Energy Industries Inc (AEIS)

HOLD. 12-month probability-weighted target $277 (-4% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

AEISEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.8%

Equity Research

Skyworks Solutions Inc (SWKS)

SELL. 12-month probability-weighted target $66 (-13% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

SWKSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -6.9%

Equity Research

NVIDIA Corporation (NVDA)

SELL. 12-month probability-weighted target $199 (-13% vs spot). Revenue Growth explains 59% of Monte Carlo outcome variance.

NVDAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -7.5%

Equity Research

Cisco Systems Inc (CSCO)

HOLD. 12-month probability-weighted target $111 (-6% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

CSCOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.9%

Equity Research

Texas Instruments Incorporated (TXN)

HOLD. 12-month probability-weighted target $276 (-3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

TXNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.3%

Equity Research

Rambus Inc (RMBS)

SELL. 12-month probability-weighted target $98 (-9% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

RMBSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -8.6%

Equity Research

Littelfuse Inc (LFUS)

HOLD. 12-month probability-weighted target $402 (-6% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

LFUSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.7%

Equity Research

Corning Incorporated (GLW)

HOLD. 12-month probability-weighted target $178 (+13% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

GLWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Lam Research Corp (LRCX)

HOLD. 12-month probability-weighted target $309 (-3% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

LRCXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.4%

Equity Research

Analog Devices Inc (ADI)

HOLD. 12-month probability-weighted target $375 (-8% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

ADIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.5%

Equity Research

Onto Innovation Inc (ONTO)

HOLD. 12-month probability-weighted target $272 (-8% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ONTOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.2%

Equity Research

FormFactor Inc (FORM)

HOLD. 12-month probability-weighted target $150 (+7% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

FORMEquity ResearchMonte Carlo

11 October 2026Rating: HOLD · Fair value vs price -12.9%

Equity Research

Synaptics Incorporated (SYNA)

HOLD. 12-month probability-weighted target $109 (-9% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

SYNAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.1%

Equity Research

Motorola Solutions Inc (MSI)

SELL. 12-month probability-weighted target $396 (-11% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

MSIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -15.5%

Equity Research

Belden Inc (BDC)

HOLD. 12-month probability-weighted target $102 (-6% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

BDCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.9%

Equity Research

Ciena Corp (CIEN)

HOLD. 12-month probability-weighted target $473 (+5% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

CIENEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.1%

Equity Research

F5 Networks Inc (FFIV)

SELL. 12-month probability-weighted target $361 (-25% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FFIVEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.0%

Equity Research

Viavi Solutions Inc (VIAV)

SELL. 12-month probability-weighted target $39 (-15% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

VIAVEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.9%

Equity Research

MACOM Technology Solutions Holdings Inc (MTSI)

SELL. 12-month probability-weighted target $266 (-19% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MTSIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.6%

Equity Research

InterDigital Inc (IDCC)

SELL. 12-month probability-weighted target $249 (-25% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

IDCCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -22.4%

Equity Research

Monolithic Power Systems Inc (MPWR)

SELL. 12-month probability-weighted target $1179 (-15% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MPWREquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -26.5%

Equity Research

Lattice Semiconductor Corporation (LSCC)

SELL. 12-month probability-weighted target $113 (-10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

LSCCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.2%

Equity Research

Teradyne Inc (TER)

SELL. 12-month probability-weighted target $353 (-12% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

TEREquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.9%

Equity Research

Entegris Inc (ENTG)

SELL. 12-month probability-weighted target $131 (-21% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

ENTGEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -31.9%

Equity Research

Lumentum Holdings Inc (LITE)

SELL. 12-month probability-weighted target $829 (-25% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

LITEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -34.2%

Equity Research

Arista Networks (ANET)

SELL. 12-month probability-weighted target $155 (-28% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ANETEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -35.9%

Equity Research

Marvell Technology Group Ltd (MRVL)

SELL. 12-month probability-weighted target $227 (-17% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

MRVLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -36.5%

Equity Research

Semtech Corporation (SMTC)

SELL. 12-month probability-weighted target $123 (-34% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

SMTCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -39.0%

Equity Research

Intel Corporation (INTC)

SELL. 12-month probability-weighted target $82 (-21% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

INTCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -40.0%

Equity Research

Advanced Micro Devices Inc (AMD)

SELL. 12-month probability-weighted target $411 (-32% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

AMDEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -48.0%

Equity Research

Sitime Corporation (SITM)

Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

SITMEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Micron Technology (MU)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MUEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Broadcom Inc (AVGO)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

AVGOEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Silicon Laboratories Inc (SLAB)

Rating suspended since 2026-10-10 — pending acquisition. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

SLABEquity ResearchMonte Carlo

30 July 2026Rating: N/A